Choosing the right animal model for sarcoma research.

Area of Science:

• Oncology
• Translational Research
• Animal Models

Background:

• Sarcomas are a diverse group of over 100 mesenchymal malignancies with significant genomic heterogeneity.
• Tumorigenic complexity influences sarcoma behavior, metastasis, and therapeutic response.
• Developing accurate animal models that mimic sarcoma's molecular and microenvironmental characteristics is essential for research.

Purpose of the Study:

• To review and evaluate various animal models for sarcoma research.
• To discuss the specific use cases, advantages, and limitations of different sarcoma models.
• To aid researchers in selecting appropriate models for preclinical studies.

Main Methods:

• Comprehensive review of existing literature on sarcoma animal models.
• Categorization and detailed analysis of syngeneic, chemically induced, cell-derived xenografts (CDX), patient-derived xenografts (PDX), humanized PDX (huPDX), and zebrafish models.
• Exclusion of genetically engineered models from the scope of this review.

Main Results:

• Identified and discussed multiple sarcoma model types, including syngeneic (MCA205, KRIMS), chemically induced (MCA, DMBA), CDX (KCS8, KCS9), PDX (leiomyosarcoma, GIST), huPDX (HuNOG-EXL), and zebrafish (tp53M214K, EWS-FLI1).
• Highlighted the specific applications, benefits, and drawbacks of each model type in the context of sarcoma research.
• Emphasized the limited availability of sarcoma-specific resources and the challenges in model selection.

Conclusions:

• The choice of animal model significantly impacts the translation of sarcoma research findings.
• Each model type offers unique advantages for studying specific aspects of sarcoma biology and treatment.
• Careful consideration of model characteristics is necessary for advancing sarcoma therapeutics.